Edwards Lifesciences Corporation: cash_and_equivalents
| Value | {"amount": 1136100000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | superseded |
| Entity | Edwards Lifesciences Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:01:16.898471+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5c613e6d-15fb-4d6f-95a6-6b181e70288c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001099800-24-000078Retrieved: 2026-08-19T11:01:16.898471+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001099800/cash-and-equivalents/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5c613e6d-15fb-4d6f-95a6-6b181e70288c
History
- supersedes {"amount": 1144000000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001099800-24-000004)